Literature DB >> 29623167

Current Indications for Stenting: Symptoms or Survival CME.

Suzanne V Arnold1.   

Abstract

The major goals of treating ischemic heart disease are to reduce angina, improve quality of life, and ultimately reduce mortality. While medical therapy can effectively address these aims, there is still much research and debate about the role of percutaneous coronary intervention in the treatment spectrum-specifically, whether or not stenting prolongs life or simply treats symptoms without impacting survival. The data supporting revascularization for survival benefit came from patients who underwent bypass graft surgery prior to the introduction of effective medical management. Although both physicians and patients continue to believe in the life-saving ability of coronary stenting, little data exist to support this belief outside of when used during an acute myocardial infarction. Strategy trials designed to test the benefit of coronary stenting have limitations that have curbed physicians' willingness to accept the results, but they provide the best evidence for how to optimally manage these patients. In this article, we explore the data supporting the use of coronary stenting for various indications and the questions that remain to be answered.

Entities:  

Keywords:  angina; coronary artery disease; coronary stenting; ischemic heart disease; percutaneous coronary intervention; revascularization

Mesh:

Year:  2018        PMID: 29623167      PMCID: PMC5880567          DOI: 10.14797/mdcj-14-1-7

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN: 1947-6108


  42 in total

1.  Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.

Authors:  Peter H Stone; Nikolay A Gratsiansky; Alexey Blokhin; I-Zu Huang; Lixin Meng
Journal:  J Am Coll Cardiol       Date:  2006-06-15       Impact factor: 24.094

2.  Appropriateness of percutaneous coronary intervention.

Authors:  Paul S Chan; Manesh R Patel; Lloyd W Klein; Ronald J Krone; Gregory J Dehmer; Kevin Kennedy; Brahmajee K Nallamothu; W Douglas Weaver; Frederick A Masoudi; John S Rumsfeld; Ralph G Brindis; John A Spertus
Journal:  JAMA       Date:  2011-07-06       Impact factor: 56.272

3.  Nuisance bleeding with prolonged dual antiplatelet therapy after acute myocardial infarction and its impact on health status.

Authors:  Amit P Amin; Alok Bachuwar; Kimberly J Reid; Adnan K Chhatriwalla; Adam C Salisbury; Robert W Yeh; Mikhail Kosiborod; Tracy Y Wang; Karen P Alexander; Kensey Gosch; David J Cohen; John A Spertus; Richard G Bach
Journal:  J Am Coll Cardiol       Date:  2013-03-26       Impact factor: 24.094

4.  β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.

Authors:  Sripal Bangalore; Gabriel Steg; Prakash Deedwania; Kevin Crowley; Kim A Eagle; Shinya Goto; E Magnus Ohman; Christopher P Cannon; Sidney C Smith; Uwe Zeymer; Elaine B Hoffman; Franz H Messerli; Deepak L Bhatt
Journal:  JAMA       Date:  2012-10-03       Impact factor: 56.272

5.  Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry.

Authors:  M Emond; M B Mock; K B Davis; L D Fisher; D R Holmes; B R Chaitman; G C Kaiser; E Alderman; T Killip
Journal:  Circulation       Date:  1994-12       Impact factor: 29.690

6.  Effect of PCI on quality of life in patients with stable coronary disease.

Authors:  William S Weintraub; John A Spertus; Paul Kolm; David J Maron; Zefeng Zhang; Claudine Jurkovitz; Wei Zhang; Pamela M Hartigan; Cheryl Lewis; Emir Veledar; Jim Bowen; Sandra B Dunbar; Christi Deaton; Stanley Kaufman; Robert A O'Rourke; Ron Goeree; Paul G Barnett; Koon K Teo; William E Boden; G B J Mancini
Journal:  N Engl J Med       Date:  2008-08-14       Impact factor: 91.245

Review 7.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

8.  Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration.

Authors:  S Yusuf; D Zucker; P Peduzzi; L D Fisher; T Takaro; J W Kennedy; K Davis; T Killip; E Passamani; R Norris
Journal:  Lancet       Date:  1994-08-27       Impact factor: 79.321

9.  Cardiologists' use of percutaneous coronary interventions for stable coronary artery disease.

Authors:  Grace A Lin; R Adams Dudley; Rita F Redberg
Journal:  Arch Intern Med       Date:  2007 Aug 13-27

10.  Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.

Authors:  Colin Baigent; Lisa Blackwell; Rory Collins; Jonathan Emberson; Jon Godwin; Richard Peto; Julie Buring; Charles Hennekens; Patricia Kearney; Tom Meade; Carlo Patrono; Maria Carla Roncaglioni; Alberto Zanchetti
Journal:  Lancet       Date:  2009-05-30       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.